Privia Health Group (NASDAQ:PRVA) Hits New 52-Week High – Here’s What Happened

Privia Health Group, Inc. (NASDAQ:PRVA)’s stock price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $23.49 and last traded at $22.98, with a volume of 96621 shares. The stock had previously closed at $22.73.

Wall Street Analyst Weigh In

Several research firms have issued reports on PRVA. Stephens reiterated an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a research report on Thursday, January 2nd. Needham & Company LLC began coverage on Privia Health Group in a research report on Friday, January 10th. They issued a “buy” rating and a $25.00 price objective for the company. Barclays increased their price objective on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. KeyCorp initiated coverage on Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price objective for the company. Finally, JPMorgan Chase & Co. raised their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $24.88.

Privia Health Group Trading Up 0.8 %

The firm has a market capitalization of $2.75 billion, a price-to-earnings ratio of 228.99, a price-to-earnings-growth ratio of 3.01 and a beta of 0.85. The firm has a 50 day moving average price of $21.00 and a two-hundred day moving average price of $19.70.

Hedge Funds Weigh In On Privia Health Group

Several hedge funds and other institutional investors have recently modified their holdings of PRVA. Canada Pension Plan Investment Board acquired a new position in shares of Privia Health Group in the 2nd quarter valued at about $26,000. GAMMA Investing LLC raised its position in shares of Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares in the last quarter. Financial Management Professionals Inc. acquired a new position in shares of Privia Health Group in the 4th quarter valued at approximately $51,000. Quarry LP raised its position in shares of Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares in the last quarter. Finally, KBC Group NV raised its position in shares of Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after acquiring an additional 871 shares in the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.